Front Page VSPN Message Boards Chat Library Continual Education Search MyVSPN - Coming Soon Help Frequently Asked Questions Send us Feedback! Go to VIN Industry Partners Go to VetQuest Go to Veterinary Partner Go to Y2Spay
 
Menu bar   Go to the VIN.com Portal
 

ABSTRACT OF THE WEEK

Theriogenology
Volume 246 | Issue 0 (October 2025)

Efficacy, safety and interval from end of treatment to estrus in cats treated with an ultra-low dose megestrol acetate protocol for suppression of reproductive activity.

Theriogenology. October 2025;246(0):117530.
Maria Pereira1, Anna Grassi2, Maja Zakošek Pipan3, Giulia Contato4, Giada Dal Ponte5, Anna Ghezzo6, Kurt G M De Cramer7, Stefano Romagnoli8
1 Department of Animal Medicine, Production and Health, University of Padova, Italy. Electronic address: mariacarlos.pereira@phd.unipd.it.; 2 Department of Animal Medicine, Production and Health, University of Padova, Italy.; 3 Clinic for Reproduction and Large Animals, Faculty of Veterinary Medicine, University of Ljubljana, Slovenia.; 4 Department of Animal Medicine, Production and Health, University of Padova, Italy.; 5 Private Practice, Vicenza, Italy.; 6 Private Practice, Venice, Italy.; 7 Rant en Dal Animal Hospital, Mogale City, Gauteng Province, South Africa; Department of Production Animal Studies, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, South Africa.; 8 Department of Animal Medicine, Production and Health, University of Padova, Italy.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.

Abstract

Cat breeders need safe, predictable and fully reversible temporary control of reproduction in queens. Megestrol acetate (MA), a short-acting progestogen was investigated in this study designed to determine whether low-dose treatment is both effective and safe in cats for periods up to 6 months. Twenty-eight queens were treated orally with 11.5 μg/kg/day of MA for one to six months. A physical examination, vaginal cytology, and reproductive ultrasound were performed before, during and after treatment, whilst urinalysis and hematological/biochemical tests, including progesterone assay, were performed before and after treatment. MA suppressed reproductive function effectively in 27/28 queens. Transient mammary and uterine hyperplasia were detected in four (14 %) and three (11 %) queens, respectively, treated for more than four months, without associated clinical signs. Pyometra was observed in only one queen following her first estrus cycle post-treatment. Significant but reversible weight gain was observed in 85 % of the animals. The resumption of cyclicity occurred on average 6 weeks after the end of treatment but was influenced by the duration of treatment and seasonality. An ultra-low dose MA treatment was effective in suppressing estrus in queens treated up to 6 months. Close monitoring should be paid to queens treated for longer than 4 months as the incidence of side effects, albeit minor and manageable, increases thereafter. Mammary gland assessment and progesterone assay are indispensable before treatment. Fertility is preserved, making MA a valuable option for temporary control of reproductive activity in queens, who otherwise cycle continuously leading to both unwanted behavior and pregnancies.

Keywords
Cats; Contraception; Megestrol acetate; Progestogens; Reproduction control;

Article Tools:
   Medline
   Email to me

Archives Highlights:
A public health campaign to increase awareness of the risk of dog bites in South Australia.
Over one third (36-37%) of dog owners and 25-29% of non-dog owners had been previously bitten by a dog, although most did not require medical attention. Approximately 70% of dog owners believed it was safe for strangers to approach their dog, 34-37% allowed children or other people to pat their dog without permission, and less than half separated their dog from visitors or delivery people. In contrast, few of the non-dog owners allowed their children to pat a dog without the owner's permission and only 2% allowed them to play with dogs without supervision.
Prevalence of discospondylitis and association with congenital vertebral body malformations in English and French bulldogs.
The prevalence of discospondylitis was 3.4 (1.6-6.7) times higher in French bulldogs and 4.3 (1.7-9.8) times higher in English bulldogs, compared with the overall hospital cohort. One or more vertebral malformations were present in 12 French bulldogs (92.3%), 6 English bulldogs (75.0%), and 1 "other" breed dog (1.1%). Discospondylitis was diagnosed adjacent to congenital vertebral body malformations in 12 (80%) intervertebral discs in French bulldogs and 5 (50%) intervertebral discs in English bulldogs.
Indications for Radiation Therapy in Veterinary Medicine
This article highlights some of the essential elements for clinical decision making in veterinary radiation oncology, with case examples to give general practitioners a better understanding of what types of cases may be appropriate for radiation therapy.
Owner survey suggests cats may be undertreated for pain compared to dogs after an elective ovariohysterectomy or orchiectomy.
Analgesics were prescribed for 19 of 162 (12%) pets: 14 of 88 (16%) dogs and 5 of 74 (6.7%) cats. There was no difference in the prescription of analgesics between dogs and cats after ovariohysterectomy or orchiectomy. 15 of 19 owners reported their compliance in administering analgesics at 78.9%. Owners' subjective assessments showed that 24 of 86 (28%) dogs and 12 of 68 (17%) cats appeared painful at home.
Trust in veterinarians and association with vaccine information sources and vaccination status among dog and cat owners.
62.9% of dog and 61.2% of cat owners were classified as trusting their veterinarians. On average, dog owners consulted 2.50 sources about vaccine information; cat owners consulted 2.27 sources. Veterinarians were the most common primary sources of information for 85.4% of dog owners with high levels of trust, but only 62.6% of dog owners with lower levels. This was the case for 83.8% and 56.3% of cat owners.

Back Print Save Bookmark in my Browser Email this article to me. Top of Page. VSPN AOW : Efficacy, safety and inte...
Contact Us